Month: October 2021

Promising New Lyme Disease Vaccine in Clinical Trials

There is promising news on the horizon for people living in areas where Lyme disease is common. Pfizer and Valneva, two pharmaceutical giants, are in Phase 2 trials to develop a vaccine that prevents Lyme disease. This potentially serious, systemic infection transmitted by… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on October 18, 2021

Treating Depression Could Lengthen Lung Cancer Patients’ Lives

Persistent depression can significantly shorten lung cancer survival – even if patients receive the latest cancer treatments, new research shows. “We need to help these patients, not only at diagnosis, but throughout treatment to take depressive symptoms out of the equation… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on October 18, 2021

Electroencephalogram Emotion Recognition Based on 3D Feature Fusion and Convolutional Autoencoder

As one of the key technologies of emotion computing, emotion recognition has received great attention. Electroencephalogram (EEG) signals are spontaneous and difficult to camouflage, so they are used for emotion recognition in academic and industrial circles. In order to overcome the disadvantage that traditional machine learning based emotion recognition technology relies too much on a […]

Published on October 18, 2021